Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Zhengye Biotechnology Holding (ZYBT) Equity Average (2024 - 2025)

Historic Equity Average for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Q2 2025 value amounting to $49.8 million.

  • Zhengye Biotechnology Holding's Equity Average changed N/A to $49.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $49.8 million, marking a year-over-year change of. This contributed to the annual value of $48.5 million for FY2024, which is 404.1% down from last year.
  • Zhengye Biotechnology Holding's Equity Average amounted to $49.8 million in Q2 2025.
  • In the past 5 years, Zhengye Biotechnology Holding's Equity Average registered a high of $49.8 million during Q2 2025, and its lowest value of $48.1 million during Q4 2024.